Modelling the characteristics of the male injecting drug user population in England and Wales

International Journal of Drug Policy

Volumn 16, Issue 3, 2005, Pages 176-182

  Sutton, Andrew J ^a,b   Gay, Nigel J ^a   Edmunds, W John ^a   Andrews, Nick J ^a   Hope, Vivian D ^a,c   Gill, O Noel ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cessation; IDU; Incidence; Injecting; Male; Modelling

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION MODEL; POPULATION RESEARCH; PRIORITY JOURNAL; UNITED KINGDOM;

EID: 20444425684     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2004.10.002     Document Type: Article

References (14)

1. Armitage, P., & Colton, T. (1998). Encyclopedia of biostatistics, Vol. 5: PRI-SPH. London: Wiley.
2. Coid, J., Carvell, A., Kittler, Z., Healey, A., & Henderson, J. (2000). Opiates, criminal behaviour, and methadone treatment (Rep. No. 120). London: Home Office.
3. P.A. Cook, J. McVeigh, Q. Syed, K. Mutton, and M.A. Bellis Predictors of Hepatitis B and C infection in injecting drug users both in and out of drug treatment Addiction 96 2001 1787 1797
4. M. Frischer, M. Hickman, L. Kraus, F. Mariani, and L. Wiessing A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain Addiction 96 2001 1465 1476
5. Godfrey, C., Eaton, G., McDougall, C., & Culyer, A. (2002). The economic and social costs of class A drug use in England and Wales, 2000 (Vol. 249). Home Office.
6. Health Protection Agency. (2003). The Unlinked Anonymous Prevalence Monitoring Programme. Website [Announcement posted on the World Wide Web]. Available from the World Wide Web: http://www.hpa.org.uk/infections/topics_az/ hiv_and_sti/hiv/epidemiology/ua.htm.
7. M. Hickman, S. Seaman, and D. de Angelis Estimating the relative incidence of heroin use: application of a method for adjusting observed reports of first visits to specialized drug treatment agencies American Journal of Epidemiology 153 2001 632 641
8. Home Office. (2002). Updated drug strategy 2002. Stationary Office.
9. V.D. Hope, P.A. Rogers, L. Jordan, T.C. Paine, S. Barnett, and J.V. Parry Sustained increase in the sharing of needles and syringes among drug users in England and Wales AIDS 16 2002 2494 2496
10. G.M. Hunter, G.V. Stimson, A. Judd, S. Jones, and M. Hickman Measuring injecting risk behaviour in the second decade of harm reduction: a survey of injecting drug users in England Addiction 95 2000 1351 1361
11. A.M. Johnson, C.H. Mercer, B. Erens, A.J. Copas, S. McManus, and K. Wellings Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours Lancet 358 2001 1835 1842
12. A.M. Johnson, J. Wadsworth, K. Wellings, and J. Field Sexual attitudes and lifestyles 1st ed. 1994 Blackwell Scientific Publications
13. A. Nicoll, O.N. Gill, C.S. Peckham, A.E. Ades, J. Parry, and P. Mortimer The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom International Journal of Epidemiology 29 2000 1 10
14. Unlinked Anonymous Surveys Steering Group. (2002). Prevalence of HIV and hepatitis infections in the United Kingdom 2001. Annual report of the Unlinked Anonymous Prevalence Monitoring Programme, Department of Health.